Randomized Controlled Trial of Surfactant Administration by Laryngeal Mask Airway (LMA)

NCT00599651 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

380

Enrollment

OTHER

Sponsor class

Stopped Study was closed due to extremely low enrollment

Conditions

Respiratory Distress Syndrome, Newborn

Interventions

DEVICE: Surfactant administered via Laryngeal Mask Airway (LMA)
OTHER: standard of care (nasal CPAP and supplemental oxygen)

Sponsor

University of Virginia

Collaborators

[object Object]
[object Object]